UnitedHealth Group stock dropped significantly, but analysts predict a rebound and see it as a buy

From Yahoo Finance: 2025-06-25 07:00:00

UnitedHealth Group (UNH) stock has dropped roughly 40% year-to-date and nearly 52% from its 52-week high. Despite challenges, the company remains a healthcare giant with a strong financial track record, generating over $400 billion in revenue in 2024. Analysts predict a rebound, with a forward P/E ratio of 12x.

UnitedHealth faces regulatory and legal challenges, including an alleged DOJ investigation. Former CEO Stephen Hemsley’s return may stabilize operations and rebuild trust with regulators and investors. Despite short-term hurdles, the company’s long-term value and growth potential make it an attractive investment opportunity for long-term investors.

With a “Moderate Buy” rating on Wall Street, UnitedHealth stock is seen as a compelling buy at current levels. Analysts project earnings to rebound in 2026. The stock’s forward P/E ratio of 12x, lower than its historical average, presents an appealing entry point for investors seeking long-term growth.

Read more: Is United Health Stock a Buy, Hold or Sell for July 2025?